Revvity Stock Today
| RVTY Stock | 111.91 1.59 1.44% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
Revvity is trading at 111.91 as of the 16th of March 2025; that is 1.44% up since the beginning of the trading day. The stock's open price was 110.32. Revvity has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on December 6, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Revvity's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 6th of April 1983 | Category Healthcare | Classification Health Care |
Revvity is entity of United States. It is traded as Stock on NYSE exchange. The company has 120.15 M outstanding shares of which 4.76 M shares are at this time shorted by private and institutional investors with about 4.89 trading days to cover. More on Revvity
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Revvity Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Prahlad Singh | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Measuring and Control Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, Measuring and Control Equipment, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsRevvity can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Revvity's financial leverage. It provides some insight into what part of Revvity's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revvity (RVTY) is traded on New York Stock Exchange in USA. It is located in 77 4th Avenue, Waltham, MA, United States, 02451 and employs 11,000 people. Revvity is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 13.45 B. Revvity conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 120.15 M outstanding shares of which 4.76 M shares are at this time shorted by private and institutional investors with about 4.89 trading days to cover.
Revvity generates positive cash flow from operations, but has no cash available
Check Revvity Probability Of Bankruptcy
Ownership AllocationRevvity owns a total of 120.15 Million outstanding shares. The majority of Revvity outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Revvity to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Revvity. Please pay attention to any change in the institutional holdings of Revvity as this could imply that something significant has changed or is about to change at the company. On December 6, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Revvity's common stock.
Check Revvity Ownership Details
Revvity Historical Income Statement
Revvity Stock Against Markets
Revvity Corporate Management
| Andrew Okun | Chief VP | Profile | |
| Joel Goldberg | General Administration | Profile | |
| Jayashree Thacker | Senior Officer | Profile | |
| Madhuri FACMG | Senior Officer | Profile | |
| Bryan Kipp | Senior Licensing | Profile | |
| Miriame Victor | Senior Officer | Profile | |
| Magali Four | Senior Officer | Profile |
Additional Tools for Revvity Stock Analysis
When running Revvity's price analysis, check to measure Revvity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revvity is operating at the current time. Most of Revvity's value examination focuses on studying past and present price action to predict the probability of Revvity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revvity's price. Additionally, you may evaluate how the addition of Revvity to your portfolios can decrease your overall portfolio volatility.